Skip To Main Content
Justine Barletta on Muck Rack

Justine Barletta

As seen in: The Lancet, Mary Ann Liebert, Inc., Archives of Pathology, The American Journal of Surgery, Diagnostic Histopathology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Justine

Contact Justine, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Higher SUVmax on FDG-PET is associated with shorter survival in adrenocortical carcinoma

|
By Sean Wrenn, Alessandra Moore, Justine Barletta, Hina J. Shah
| The American Journal of Surgery Verified
Adrenocortical carcinoma (ACC) is an aggressive, rare malignancy. 2-deoxy-2-[18F]-fluoro- -glucose positron emission tomography (FDG-PET) assesses tumor metabolism and glucose utilization. We hypothesized that higher maximum standard uptake value (SUV ) is associated with decreased survival. We performed a retrospective analysis of patients with ACC. Included patients (n = 26) had an FDG-PET scan available with a documentable SUV .
Open in Who Shared Issue with article?

Management of thyroid nodules

|
By Erik Alexander, Gerard M. Doherty, Justine Barletta
| The Lancet Verified
1. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 2022; 10: 533-539 2. Baloch ZW Asa SL Barletta JA et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022; 33: 27-63 3. Namba H Matsuo K Fagin JA Clonal composition of benign and malignant human thyroid tumors. J Clin Invest. 1990; 86: 120-125 4. Marcadis AR Valderrabano P Ho AS et al.
Open in Who Shared View Duplicates (25) Issue with article?

Hürthle cell neoplasms

|
By Stephanie E. Siegmund, Iñigo Landa, Kristine Wong, Justine Barletta
| Diagnostic Histopathology Verified
Abstract Hürthle cells (HC) are characterized by abundant granular eosinophilic cytoplasm containing accumulated dysfunctional mitochondria and large nuclei with prominent nucleoli. Based on the distinct clinicopathologic and molecular characteristics of Hürthle cell neoplasms (HCN), the 2017 Endocrine World Health Organization (WHO) moved to categorizing HCN as a separate group of tumors.
Open in Who Shared Issue with article?
See all 4 licensed articles (5 Total)